Summary
The metabolism of 5′-deoxy-5-fluorouridine (5′dFUrd), an antitumor fluoropyrimidine, has been investigated in human biofluids (blood, plasma, urine) using a new method: fluorine-19 NMR spectrometry. This method allows direct study of the biological sample and simultaneous identification of all the fluorinated metabolites. In the blood of a patient treated with 5′dFUrd during a 6-h continuous perfusion, we observed unmetabolized 5′dFUrd, 5-fluorouracil, 5,6-dihydrofluorouracil, and another metabolite which has not previously been reported α-fluoro-β-alanine. The two major metabolites in urine are unmetabolized 5′dFUrd and α-fluoroβ-alanine.
Similar content being viewed by others
References
Abraham RJ, Loftus P, Thomas WA (1977) Rotational isomerism XXI. The conformation of 2-amino-3-fluoropropanoic acid (2-AFP) and 2-fluoro-3-aminopropanoic acid (3-AFP) as the zwitterion, cation and anion, an NMR and MO study. Tetrahedron 33:1227
Armand JP, Hurteloup P, Mathé G (1983) Phase II study of 5′-deoxy-5-fluorouridine for advanced solid tumors. Proceedings of the Second European Conference on Clinical Oncology, Amsterdam
Armstrong RD, Cadman E (1983) 5′Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow. Cancer Res 43:2525
Armstrong RD, Diasio RB (1979) 5′-Deoxy-5-fluorouridine: cellular metabolism of a new fluoropyrimidine with antineoplastic activity. Proc Am Assoc Cancer Res 260:1054
Armstrong RD, Diasio RB (1980) Metabolism and biological activity of 5′-deoxy-5-fluorouridine, a novel fluoropyrimidine. Cancer Res 40:3333
Armstrong RD, Diasio RB (1981) Selective activation of 5′-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index. Cancer Res 41:4891
Aubert C, Sommadossi JP, Coassolo P, Cano JP, Rigault JP (1982) Quantitative analysis of 5-fluorouracil and 5,6-dihydro-fluorouracil in plasma by gas chromatography mass spectrometry. Biomed Mass Spectrom 9:336
Bollag W, Hartmann HR (1980) Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridine Eur J Cancer 16:427
Cano JP, Sommadossi JP, Rigault JP, Gouveia J, Ribaud P, Mathé G (1981) Phse I. Preliminary clinical pharmacokinetic studies of 5′-deoxy-5-fluorouridine (5′d FUR) in cancer patients using HPLC and GC/MS methods. Proc Am Assoc Cancer Res 191:759
Chaudhuri NK, Mukherjee KL, Heidelberger C (1958) Studies on fluorinated pyrimidines VII. The degradative pathway. Biochem Pharmacol 1:328
Connoly KM, Diasio RB, Armstrong RD, Kaplan AM (1983) Decreased immunosuppression associated with antitumor activity of 5′-deoxy-5-fluorouridine compared to 5-fluorouracil and 5-fluorouridine. Cancer Res 43:2529
Diasio RB, Bowen D (1978) Rapid simultaneous analysis of fluoropyrimidine metabolite pools by a high-performance liquid chromatography-isotopic method. Proc Am Assoc Cancer Res 132:528
Ishitsuka H, Miwa M, Takemoto K, Fukuoka K, Itoga A, Maruyama HB (1980) Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine. Gan 71:112
Kramer MJ, Trown PW, Cleeland R, Cook AF, Grunberg E (1979) 5′-Deoxy-5-fluorouridine. A new orally active antitumor agent. Comparative activity with 5-fluorouracil, 2′-deoxy-5-fluorouridine and ftorafur against transplantable tumors in mice and rats. Proc Am Assoc Cancer Res 20:79
Mukherjee KL, Heidelberger C (1960) Studies on fluorinated pyridimines. IX. The degradation of 5-fluorouracil-6-C14. J Biol Chem 235:433
Myers CE (1981) The pharmacology of the fluoropyrimidines. Pharmacol Rev 33:1
Ohta Y, Sueki K, Kitta K, Takemoto K, Ishisuka H, Yagi Y (1980) Comparative studies on the immunosuppressive effect among 5′-deoxy-5-fluorouridine, ftorafur and 5-fluorouracil. Gan 71:190
Sommadossi JP, Cano JP (1981) Determination of a novel fluoropyrimidine in plasma by high-performance liquid chromatography. J Chromatogr 225:516
Sommadossi JP, Gewirtz DA, Diasio RB, Aubert C, Cano JP, Goldman ID (1982) Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high-performance liquid chromatography. J Biol Chem 257:8171
Sommadossi JP, Aubert C, Cano JP, Gouveia J, Ribaud P, Mathé G (1983) Kinetics and metabolism of a new fluoropyrimidine, 5′-deoxy-5-fluorouridine, in humans. Cancer Res 43:930
Suzuki S, Hongu Y, Fuzakawa H, Ichihara S, Shimizu H (1980) Tissue distribution of 5′-deoxy-5-fluorouridine and derived 5-fluorouracil in tumor-bearing mice and rats. Gan 71:238
Ts'o POP (1974) Bases, nucleosides and nucleotides. In: Ts'o POP (ed) Basic principles in nucleic acid chemistry. Academic Press, New York, p 453
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malet-Martino, MC., Martino, R., Lopez, A. et al. New approach to metabolism of 5′-deoxy-5-fluorouridine in humans with fluorine-19 NMR. Cancer Chemother. Pharmacol. 13, 31–35 (1984). https://doi.org/10.1007/BF00401443
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00401443